News about Manufacturing

OXB Signs Multi-Year Commercial Supply Deal with Bristol Myers Squibb

Oxford Biomedica will serve as the commercial manufacturer of lentiviral vectors for Bristol Myers Squibb’s CAR-T programmes under a new multi-year supply agreement, which includes a five-year initial term with an option to extend.

Manufacturing | 05/02/2026 | By News Bureau

Telangana Cracks Down on Illegal Medical Device Manufacturing in Ranga Reddy

The Drugs Control Administration (DCA) of Telangana has uncovered an unlicensed medical device manufacturing and distribution operation in the Ranga Reddy district, leading to the seizure of products and supporting materials valued at Rs 4 lakh.

Manufacturing | 05/02/2026 | By Darshana

FDA Launches PreCheck Pilot to Strengthen Domestic Drug Manufacturing

The USA Food and Drug Administration (FDA) has launched a new pilot initiative aimed at strengthening domestic drug manufacturing and reinforcing the country’s pharmaceutical supply chain.

Manufacturing | 03/02/2026 | By Darshana

Piramal Pharma Acquires Global Rights to Kenalog Brand in Up to USD 100 Million Deal

Piramal Pharma has agreed to acquire the global rights to the Kenalog brand and its associated injectable corticosteroid products from Bristol-Myers Squibb in a deal valued at up to USD 100 million. The acquisition will be executed through Piramal’s wholly owned subsidiary, Piramal Critical Care B.V.

Manufacturing | 02/02/2026 | By Darshana |  123

Lilly Announces USD 3.5 Billion Injectable Drug and Device Manufacturing Facility in Pennsylvania

Eli Lilly and Company has announced plans to invest USD 3.5 billion to build a new injectable drug and device manufacturing facility in the Lehigh Valley region of Pennsylvania, marking one of the largest life sciences investments in the state’s history.

Manufacturing | 31/01/2026 | By Darshana |  137

Cellares Moves Cell Therapy Manufacturing from Platform to Patients

The cell and gene therapy (CGT) sector is entering a phase of more disciplined and sustainable growth after years of volatility, according to industry leaders speaking at the 2026 Biotech Showcase in San Francisco.

Manufacturing | 29/01/2026 | By Darshana |  108

Siegfried Expands U.S. Manufacturing Capacity with Acquisition of Two Facilities

Siegfried, the Switzerland-based contract development and manufacturing organisation (CDMO), is expanding its manufacturing presence in the United States through the acquisition of two pharmaceutical production facilities.

Manufacturing | 28/01/2026 | By Darshana |  150

Naprod Life Sciences Secures ANVISA GMP Renewal for Tarapur Facility

Naprod Life Sciences has received renewal of its Good Manufacturing Practice (GMP) certification from Brazil’s health regulator, ANVISA, for its Tarapur manufacturing facility in Maharashtra.

Manufacturing | 27/01/2026 | By Darshana

SK bioscience, MSD and Hilleman Advance Ebola Vaccine with CEPI Funding

he collaboration will receive up to USD 30 million in CEPI funding to support development of MSD’s Zaire ebolavirus vaccine, with a focus on improving manufacturing efficiency, enhancing thermostability and expanding affordable vaccine access in low- and middle-income countries.

Manufacturing | 23/01/2026 | By News Bureau |  109

India Cuts Review Period for Clinical Trial Drug Manufacturing to 45 Days

The central government has reduced the approval timeline for applications to manufacture drugs meant for clinical trials, a move aimed at accelerating clinical research and drug development in India.

Manufacturing | 22/01/2026 | By Darshana |  179